BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 9556553)

  • 1. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
    Kishida S; Yamamoto H; Ikeda S; Kishida M; Sakamoto I; Koyama S; Kikuchi A
    J Biol Chem; 1998 May; 273(18):10823-6. PubMed ID: 9556553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level.
    Nakamura T; Hamada F; Ishidate T; Anai K; Kawahara K; Toyoshima K; Akiyama T
    Genes Cells; 1998 Jun; 3(6):395-403. PubMed ID: 9734785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex formation of adenomatous polyposis coli gene product and axin facilitates glycogen synthase kinase-3 beta-dependent phosphorylation of beta-catenin and down-regulates beta-catenin.
    Hinoi T; Yamamoto H; Kishida M; Takada S; Kishida S; Kikuchi A
    J Biol Chem; 2000 Nov; 275(44):34399-406. PubMed ID: 10906131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin.
    Hedgepeth CM; Deardorff MA; Rankin K; Klein PS
    Mol Cell Biol; 1999 Oct; 19(10):7147-57. PubMed ID: 10490650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
    Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
    Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
    J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A.
    Yamamoto H; Hinoi T; Michiue T; Fukui A; Usui H; Janssens V; Van Hoof C; Goris J; Asashima M; Kikuchi A
    J Biol Chem; 2001 Jul; 276(29):26875-82. PubMed ID: 11297546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
    Willert K; Shibamoto S; Nusse R
    Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.
    Hart MJ; de los Santos R; Albert IN; Rubinfeld B; Polakis P
    Curr Biol; 1998 May; 8(10):573-81. PubMed ID: 9601641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of beta-catenin by the colorectal tumor suppressor APC requires association with Axin and beta-catenin.
    Kawahara K; Morishita T; Nakamura T; Hamada F; Toyoshima K; Akiyama T
    J Biol Chem; 2000 Mar; 275(12):8369-74. PubMed ID: 10722668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of the Axin-adenomatous polyposis coli interaction.
    Spink KE; Polakis P; Weis WI
    EMBO J; 2000 May; 19(10):2270-9. PubMed ID: 10811618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification.
    Farr GH; Ferkey DM; Yost C; Pierce SB; Weaver C; Kimelman D
    J Cell Biol; 2000 Feb; 148(4):691-702. PubMed ID: 10684251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axin prevents Wnt-3a-induced accumulation of beta-catenin.
    Kishida M; Koyama S; Kishida S; Matsubara K; Nakashima S; Higano K; Takada R; Takada S; Kikuchi A
    Oncogene; 1999 Jan; 18(4):979-85. PubMed ID: 10023673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Wnt signaling pathway by a novel axin-binding protein.
    Kadoya T; Kishida S; Fukui A; Hinoi T; Michiue T; Asashima M; Kikuchi A
    J Biol Chem; 2000 Nov; 275(47):37030-7. PubMed ID: 10944533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Wnt signaling by Axin and Axil.
    Kikuchi A
    Cytokine Growth Factor Rev; 1999; 10(3-4):255-65. PubMed ID: 10647780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.
    Schneikert J; Ruppert JG; Behrens J; Wenzel EM
    PLoS One; 2014; 9(4):e94413. PubMed ID: 24722208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axin directly interacts with plakoglobin and regulates its stability.
    Kodama S; Ikeda S; Asahara T; Kishida M; Kikuchi A
    J Biol Chem; 1999 Sep; 274(39):27682-8. PubMed ID: 10488109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.